Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence

By LabMedica International staff writers
Posted on 29 Jan 2024

The global healthcare industry is increasingly embracing Artificial Intelligence (AI) to drive scientific breakthroughs, create new treatments, and enhance health outcomes for a wide range of medical conditions. More...

Medlab Middle East, an event organized by Informa Markets Healthcare (London, UK), is set to explore AI's crucial role in laboratories. Experts will converge for the 23rd edition of Medlab Middle East from February 5-8 at the Dubai World Trade Centre where the focus will be on revolutionizing laboratory medicine and introducing sustainable solutions. A new show vertical, in partnership with Express Med Diagnostics and Research (Manama, Bahrain), will spotlight Next Generation medicine, featuring product categories like technology, innovation, general services, imaging, infrastructure, IT, laboratory, medical equipment, pharma, and nutrition.

AI's application in medical imaging is witnessing an increase in the UAE, bolstered by several government initiatives. In Dubai, healthcare organizations are effectively utilizing AI for medical imaging, including automated detection of breast cancer and lung diseases. Saudi Arabia recently introduced the country's first AI-powered eye screening tests for diabetic retinopathy, enhancing diagnostic accuracy and efficiency. AI is also expediting the discovery of new medicines in the region by simulating trial-and-error processes in a computer to determine optimal drug compositions. In October 2023, the UAE launched its first Centre for Excellence (COE) in AI, providing services like an organ donation and transplant center. This facility leverages AI to match donors with patients and prioritize urgent cases, both domestically and internationally. The Centre is also planning to deploy AI for analyzing radiological scans, aiming to improve diagnostic efficiency. An AI lab is expected to launch soon at the Centre.

Professor Hassan Ugail, Director of the Centre for Visual Computing and Intelligent Systems at the University of Bradford (Bradford, UK), is scheduled to speak at Medlab Middle East as part of the ‘Digitalization, Automation and Innovation’ session, on the second day of the NextGen Conference. Professor Ugail has been responsible for leading the development of a pioneering AI tool called “OrQA” (Organ Quality Assessment), which examines the quality of human organs for transplantation. Time is a critical factor when it comes to evaluating organs for transplantation. OrQA can provide detailed and reliable analysis in just seconds. The AI method uses a scoring system to grade an organ between zero and five, with organs that score below four, being suitable for use. There are plans to take the tool worldwide in the coming year.

“We use state-of-the-art artificial intelligence techniques to train a machine learning algorithm and worked with a number of surgeons to ‘score’ a range of organs. The machine then learns about the scores, alongside other characteristics such as the color, texture and shape of the organ,” said Professor Ugail. “Traditionally when an organ becomes available for transplantation, you need to gather experts as quickly as possible for an assessment. With OrQA, an image of that organ can be uploaded and it will quickly provide a score. It is an excellent application of AI for real healthcare use and helps surgeons to make the best possible decisions in the quickest possible time.”

“The integration of AI into laboratory practices is already redefining the landscape of scientific discovery and driving innovation in healthcare. In the years to come, the need for AI in medical imaging will continue to grow,” added Tom Coleman, Exhibition Director, Informa Markets Healthcare. “AI technologies are able to process and analyze data more quickly and accurately leading to new insights in various realms of study, and we are excited to spotlight this exciting field of healthcare at Medlab Middle East.”

Related Links:
Informa Markets Healthcare
Express Med Diagnostics and Research
University of Bradford


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.